Accelerated Resolution Therapy: Randomized Controlled Trial of a Complicated Grief Intervention
| Autor: | Diego F. Hernandez, Cindy Tofthagen, Jesse Bell, Paula Cairns, Harleah G. Buck, Philip Barrison, Nnadozie Emechebe, Kevin E. Kip, Tina M. Mason |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Male
Pediatrics medicine.medical_specialty Article law.invention Stress Disorders Post-Traumatic 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Surveys and Questionnaires Intervention (counseling) medicine Humans Depression (differential diagnoses) Aged 030504 nursing business.industry General Medicine medicine.disease Complicated grief Psychotherapy Caregivers Female Grief 0305 other medical science business 030217 neurology & neurosurgery |
| Zdroj: | Am J Hosp Palliat Care |
| ISSN: | 1938-2715 1049-9091 |
| Popis: | Background and Objectives: Complicated grief (CG) is severe, prolonged (>12 months) grieving. Complicated grief disproportionately affects older adults and is associated with negative physical/psychological effects. Although treatment options exist, those which do are time-intensive. We report on a randomized clinical trial (RCT) which examined whether accelerated resolution therapy (ART), a novel mind-body therapy, is effective in treating CG, post-traumatic stress disorder (PTSD), and depression among hospice informal caregivers. Research Design and Methods: Prospective 2 group, wait-listed RCT. All participants were scheduled to receive 4 ART sessions. Inclusion: ≥60 years, inventory of CG >25, and PTSD checklist for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition >33 or Psychiatric Diagnostic Screen Questionnaire PTSD subscale >5. Exclusion: Major psychiatric disorder, other current psychotherapy treatment. Depression was measured by the Center for Epidemiologic Studies Depression. Results: Mean (standard deviation [SD]) age of 54 participants was 68.7 (7.2) years, 85% female, and 93% white. Participants assigned to ART reported significantly greater mean (SD) CG reduction (−22.8 [10.3]) versus Wait-list participants (−4.3 [6.0]). Within-participant effect sizes (ESs) for change from baseline to 8-week post-treatment were CG (ES = 1.96 (95% confidence interval [CI]: 1.45-2.47; P < .0001), PTSD (ES = 2.40 [95% CI: 1.79-3.00]; P < .0001), depression (ES = 1.63 [95% CI: 1.18-2.08; P < .0001). Treatment effects did not substantially differ by baseline symptom levels. Discussion and Implications: Results suggests that ART presents an effective and less time-intensive intervention for CG in older adults. However, it should undergo further effectiveness testing in a larger, more diverse clinical trial with a focus on determining physiological or behavioral mechanisms of action. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|